Top Markets
#1 Trillions Trillions +4,371.22%
#2 Ozapay Ozapay +37.63%
#3 UnifAI Network UnifAI Network +26.77%
#4 Aria.AI Aria.AI +21.95%
#5 Zano Zano +17.34%
#6 Osaka Protocol Osaka Protocol +14.21%
#7 StakeStone StakeStone +13.94%
#8 Vestra DAO Vestra DAO +11.91%
#9 River Pts River Pts +10.84%
#10 pippin pippin +10.64%
Coin of the day
Trillions Trillions
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Acticor Biotech SAS Acticor Biotech SAS

Acticor Biotech SAS

ALACT
Classement en actions #99999
Acticor Biotech SAS operates as a clinical stage biotechnology company that... Acticor Biotech SAS operates as a clinical stage biotechnology company that develops drugs for the treatment of acute phase of thrombotic diseases. The company develops glenzocimab, a humanized monoclonal antibody fragment that targets a specific platelet glycoprotein. It is also involved in two clinical programs in Phase II/III registration for the treatment of ischemic stroke; and two other Phase II trials addressing major cardiovascular emergencies with clinical results expected in ischemic stroke and Covid-19 respiratory distress syndrome. The company was incorporated in 2013 and is headquartered in Paris, France.
Prix de l'action
$0.28545656
Capitalisation boursière
$4.50M
Changement (1 jour)
5.97%
Changement (1 an)
0.00%
Pays
FR
Échange Acticor Biotech SAS (ALACT)

Catégorie

Healthcare
Ratio P/B pour Acticor Biotech SAS (ALACT)
Ratio P/B au March 2026 TTM : -0.57
Selon les derniers rapports financiers et le cours de l'action de Acticor Biotech SAS, le ratio cours/valeur comptable actuel (TTM) est -0.57. À la fin de 2022, le ratio P/B était de -33.19.
Historique du ratio P/B pour Acticor Biotech SAS de 2010 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
2026 (TTM) -0.57 -91.38%
2023 -6.59 -80.15%
2022 -33.19 -1,126.36%
2021 3.23 -87.62%
2020 26.12 538.96%
2019 4.09 17.85%
2018 3.47 -160.01%
2017 -5.78 -511.84%
2016 1.40 2.83%
2015 1.37 7.92%
2014 1.26 5.23%
2013 1.20 -8.34%
2012 1.31 -12.44%
2011 1.50 -91.22%
2010 17.05 0.00%
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 5.6573 -1,096.18%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3842 -1,224.18%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 2.4551 -532.31%
US
UCB SA UCB SA
UCB SA
UCB.BR
 4.364 -868.45%
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5504 -549.09%
AU